While CPG brands move digital in-house, pharma continues to rely on agencies

  •  91% of brands have moved at least a part of their digital marketing operations in-house. (Source: Search Engine Journal)
  • Cost efficiency, greater control, and increased transparency are amongst the biggest reasons for in-housing.
  •  56% of respondents say a lack of existing talent and skills to build a competent in-house team in the biggest obstacle.
Continue reading

How is Pfizer employee morale?

  • 41 of Pfizer’s drugs have been picked for a price hike on January 15, averaging 5%.
  • Pfizer noted Friday that the increases will be offset by higher rebates and discounts offered to insurance companies and pharmacy benefit managers.
  • Pfizer had the highest profit total ($4.1 billion) of any publicly traded health care company in the third quarter.

Continue reading

Above all pharma companies are a business

  • Pharma companies don’t really care about patients despite all their hubris.
  • PhRMA has already spent $21 million on lobbying this year — a sum that puts it on course to smash its previous annual lobbying records.
  • Pharmaceutical companies have been top performers in the healthcare sector in an era of aging populations, rising health care costs, and the ongoing development of new and extremely profitable medicines.
  • Research shows that 78 percent of patents approved by the U.S. Food and Drug Administration correspond to medications already on the market.
  • Large pharma companies spend more on share buybacks to boost share prices (and stock options — the main way that executives get paid) than on research and development.

Continue reading

Pharma gives the middle finger to patients

  • President Donald Trump in May said that drugmakers would soon announce “massive” price cuts but they aren’t in the loop.
  • Bayer raised the price of two cancer drugs by hundreds of dollars in May and Novartis followed by boosting four pricey treatments in June. [inlinetweet prefix=”” tweeter=”” suffix=””]Pfizer, one of the largest U.S. pharma companies, announced increases on more than 41 products this week.[/inlinetweet]
  • [inlinetweet prefix=”” tweeter=”” suffix=””]A Wells Fargo report found 104 price increases in June and the first two days of July[/inlinetweet], with an average jump of 31.5 percent and a median increase of 9.4 percent. That followed 48 increases in May.

Continue reading